What is Neil Woodford doing?

The much-celebrated fund manager is testing the patience of his investors, says Sarah Moore.

937-barratt-634

Barratt Developments: Woodford's a fan

The much-celebrated fund manager is testing the patience of his investors.

Former star fund manager Neil Woodford has stirred up controversy yet again this week, after his Woodford Equity Income fund swapped five of its unlisted stocks for shares in Woodford's Patient Capital Investment Trust.

On the one hand, the move makes sense. It was always odd to have an equity income fund investing some of its money into unquoted companies that pay no dividends. It also makes a lot more sense to hold these sorts of illiquid assets within an investment trust that specialises in early stage companies, than within an open-ended fund. The latter can run into problems with illiquid assets if too many investors want their money back at once, which is almost certainly another factor behind the move, as we'll get to shortly.

On the other hand, you can see why investors in the equity income fund might be upset. Like many investment trusts, Patient Capital trades at a discount to its net asset value (NAV the value of the underlying portfolio). At the time of the deal, this discount was 13%. So if you had bought the shares in the open market, you'd have paid around 87p for every £1 of NAV. Yet the fund didn't do this instead it paid the equivalent of the NAV for each share.

In other words, it overpaid by about 15%. Woodford and his representatives argue that the alternative (buying the shares in the market) would have been too expensive and time-consuming, and that they've paid "what the trust's assets are actually worth" but investors who were already wavering could be forgiven for considering this the final straw.

A big past to live up to

However, performance has deteriorated since, with the fund underperforming in each of the last three years. Unsurprisingly, this underperformance prompted investors to withdraw their cash the amount of money invested in Woodford Equity Income has more than halved to below £5bn since launch meaning that Woodford had to sell holdings in order to meet investor redemptions.

Given that it's harder to sell shares in unlisted companies quickly, this has meant that Woodford has had to sell down some of the portfolio's larger, more liquid holdings. As a result, the portfolio has ended up being much more heavily-weighted to smaller, riskier companies. At one point, the portfolio was more than 50% invested in FTSE 100 stocks; this proportion is now less than 20%.

Faith isn't always enough

If you still have faith in Woodford, hang on. If, instead, you're looking for a reliable income, you might look at the Troy Trojan Income fund, which yields 4.4% and topped insurer Sanlam's latest list of UK equity income funds.

Or if you specifically want to invest in early-stage life-sciences firms, you may instead choose to wait for shares in investment trust Syncona (LSE: SYNC), which has done very well in recent years, to trade at a lower premium to NAV (the premium is currently a massive 35%).

Activist watch

The activist investor has written to L Brands's chief executive and chairman, Leslie Wexner, arguing that Victoria's Secret could be "rejuvenated" by improving merchandise and updating its branding, and calling for board directors, including those with tenures of longer than 30 years, to be replaced. Wexner, who founded and has run L Brands for more than 50 years, controls roughly 17% of the shares. By contrast, Barington Capital owns under 1% of the company.

Short positions... cannabis ETF gets high

Biogen's offer of $25.5 per share represents a 70% premium to Nightstar's recent share price, though it is below the $26.42 peak hit last September. Syncona, which owns a 38.8% stake in Nightstar, has achieved a 4.5-times return on its £56.4m investment in the company. Syncona will not return any of the money to shareholders, but will use it to make further investments in its portfolio of 13 holdings and pipeline of new companies. The acquisition is also good news for fund manager Neil Woodford (see above): his equity income fund holds 0.25% of its assets in Nightstar.

The world's first cannabis exchange-traded fund (ETF) is set to become the second-most profitable ETF in Canada, says the Financial Times. The Horizons Marijuana Life Sciences Index fund has returned more than 50% so far in the year-to-date, amid a frenzy for cannabis-related stocks. The fund's high annual management charge (0.75%, high for an ETF, particularly compared to more general trackers) and ability to earn fees from lending stock (for cannabis sceptics to short-sell) means it is fast catching up to Canada's most profitable ETF, which is five times larger.

Recommended

Woodford investor? Your first payment is coming soon
Neil Woodford

Woodford investor? Your first payment is coming soon

Private investors left stranded by the collapse of the Woodford Equity Income fund will soon be getting at least some of their money back. But they wi…
28 Jan 2020
Forget rebalancing – ditch your losers, not your winners
Sponsored

Forget rebalancing – ditch your losers, not your winners

Investors are often told to regularly rebalance their portfolio and take profits from their winning holdings. But that can be a mistake, says Max King…
26 Jan 2021
All you need to know about exchange-traded funds
Funds

All you need to know about exchange-traded funds

The transparency and liquidity of exchange-traded funds make them popular with investors, but there are still a few things you should know before you …
22 Jan 2021
The best investment trusts to buy for 2021
Investment trusts

The best investment trusts to buy for 2021

Sectors ranging from emerging markets to student accommodation look poised to do well this year, says David Stevenson, as he picks the best investment…
19 Jan 2021

Most Popular

The FTSE 100 is set for a makeover with an influx of new tech stocks
UK stockmarkets

The FTSE 100 is set for a makeover with an influx of new tech stocks

The FTSE 100 – the dullest index in the world – is about to reinvent itself as a host of new firms list on the market. The change is long overdue, say…
24 Jan 2021
Why we won’t see a house-price crash in 2021
House prices

Why we won’t see a house-price crash in 2021

Lockdown sent house prices berserk as cooped up home-workers fled for bigger properties in the country. And while they won’t rise quite as much this y…
18 Jan 2021
Think Tesla is a bubble? This might be the best way to bet on it bursting
Oil

Think Tesla is a bubble? This might be the best way to bet on it bursting

The huge rise in Tesla’s share price means that, by market value, it’s now the sixth-largest company in the US and and the world’s biggest car-maker. …
25 Jan 2021